Hutch News
Results per Page:
How does leukemia escape from immunotherapy?
Single-cell sequencing tech enables deep dive into mysterious results, sets stage for future improvements
Fred Hutch at ASH: Fauci fireside chat, latest on cell therapies, repairing immune function, COVID and clots — and more
The 62nd American Society of Hematology Annual Meeting and Exposition to be held virtually Dec. 5-8, 2020
99 problems when n=1?
In research, (sample) size matters
Science on the horizon
Fred Hutch experts make predictions for science trends, advances in 2020
Scientists gather in Seattle to share strategies for an HIV cure
Workshop focuses on ways to lower cost, broaden reach of gene therapy
Immunotherapy prevents relapse in small leukemia trial
Engineered T cells kept leukemia from returning in 12 high-risk patients
$12M NIH grant to study rare, aggressive skin cancer
Fred Hutch, UW researchers hope to improve immunotherapies for people with Merkel cell carcinoma
Seattle mayor and melanoma survivor Jenny Durkan visits Fred Hutch
Mayor shares personal story as Hutch scientists outline the future of cancer therapy
‘Let the cells tell the story’
New tech is giving scientists unprecedented insights into single cells’ inner workings
Molecular mechanisms of late cancer relapse
from the Chapuis lab, Clinical Research Division
Revealing a new way that cancer can evade immunotherapy — and, maybe, how to stop it
How a new technology solved a mystery and honors one man’s legacy
Cancer cells evade immunotherapy by hiding telltale marker, suggesting how to stop relapse
A Nature Communications report explains why some Merkel cell carcinoma patients treated with immunotherapy see their cancers shrink at first but then come back.
Good News: Fred Hutch joins coalition that seeks to increase transparency on life science career prospects
Celebrating faculty and staff achievements
Science without borders
At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases
Triple therapy for rare skin cancer shows promise in small, early-stage trial
Combo of T-cell therapy, newly FDA-approved drug and another immune booster kept cancer at bay for three of four patients with metastatic Merkel cell carcinoma
5 researchers receive awards to explore immunotherapy single-cell RNA sequencing
Projects accelerate Hutch position as early adopter of scRNA-seq technology
Good News: Dr. Nancy Davidson, former VP Joe Biden and others share cancer insights
Celebrating faculty and staff achievements
Immunotherapy shows promise in preventing leukemia relapse
Group of 12 high-risk patients who received engineered T cells after bone marrow transplant still in remission